Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NIVF vs BSLK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NIVF Wins Head-to-Head Institutional Verdict (2–1 across 6 Pillars · 5–3 Matrix Metrics)

NIVF Overall Winner 6-Pillar Tally: NIVF 2 – 1 BSLK (3 Tie) Matrix Metrics: NIVF 5 – 3 BSLK

As of Nov 16, 2026, NewGenIvf Group Limited Class A (NIVF) is the stronger overall head-to-head candidate over Bolt Projects Holdings, Inc. (BSLK) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 2–1 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow). NIVF carries a Unified Composite Score of 42.4/100 (HOLD) at $0.20 (N/M Forward P/E, -238.2% operating margin), whereas BSLK carries 41.2/100 (SELL) at $0.58 (N/M Forward P/E, -1179.5% operating margin).

  • Growth vs. Quality Trade-Off: NIVF earns the overall head-to-head edge with a stronger Unified Composite Score (42.4/100 HOLD vs. BSLK 41.2/100 SELL) and 0.07β · 3093% Vol risk profile, whereas BSLK leads top-line expansion (+7300.0% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: NIVF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.2); meanwhile BSLK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 19.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NIVF vs BSLK
NIVF NASDAQ Head-to-Head Winner
NewGenIvf Group Limited Class A ordinary shares
Services-Misc Health & Allied Services, Nec
$0.20
-11.33% 1D
Market Cap $369,508
TTM Revenue $4.6M
Forward P/E N/M
Beta / 30D Vol 0.07β · 3093% Vol
Unified Composite Score
42.4 / 100 HOLD
Tech 40.0 Fund 40.0 Flow 50.0 Mom 45.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.1%), weak momentum, RSI 38
RSI-14: 38.2 · SMA20: $0.64 · SMA50: $0.54
BSLK NASDAQ
Bolt Projects Holdings, Inc. Common Stock
Industrial Organic Chemicals
$0.58
-27.01% 1D
Market Cap $7.1M
TTM Revenue $3.1M
Forward P/E N/M
Beta / 30D Vol 4.04β · 148% Vol
Unified Composite Score
41.2 / 100 SELL
Tech 40.0 Fund 43.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.4%), weak momentum, RSI 20
RSI-14: 19.8 · SMA20: $1.63 · SMA50: $1.95

6-Pillar Scorecard Institutional Category Breakdown (NIVF 2 – 1 BSLK)

Columns: Metric · NIVF · BSLK
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M 0.1x
PEG Ratio N/M N/M
EV / Revenue 0.1x 4.9x
2. Growth & Scale BSLK
Revenue Growth (YoY) -4.7% +7300.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $4.6M $3.1M
Market Cap $369,508 $7.1M
3. Profitability & Quality NIVF
Gross Margin 23.9% 3.2%
Operating Margin -238.2% -1179.5%
Net Profit Margin 24.2% 0.0%
Return on Equity (ROE) 5.5% -4288.3%
4. Balance Sheet & Cash Flow NIVF
Cash Generation (TTM) -$11M EBITDA -$5.4M
Cash Flow Margin N/A N/A
Net Cash / Leverage $733.75 Book/Sh · 5.5% ROE $8.2M Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Care Facilities Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NIVF (5) vs BSLK (3)
Institutional Metric NIVF BSLK Criterion Row Edge
Market Capitalization
Scale
$369,508 $7.1M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M 0.1x Lower Multiple BSLK
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-4.7% +7300.0% Higher Growth BSLK
Operating Margin (TTM)
Profitability
-238.2% -1179.5% Higher Margin NIVF
Net Profit Margin
Profitability
24.2% 0.0% Higher Margin NIVF
Return on Equity (ROE)
Capital Efficiency
5.5% -4288.3% Higher ROE NIVF
52-Week Range Position
Momentum
5% ($0–$3) 0% ($1–$25) Stronger Trend NIVF
Beta / 30D Volatility
Risk Regime
0.07β · 3093% Vol 4.04β · 148% Vol Lower Realized Risk BSLK
Unified Institutional Score
Composite Signal
42.4 / 100 (HOLD) 41.2 / 100 (SELL) Higher Composite NIVF
Trailing 12M Revenue (USD)
Operating Scale
$4.6M $3.1M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
23.9% 3.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev N/M PEG · 4.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$11M EBITDA ($733.75 Book/Sh · 5.5% ROE) -$5.4M ($8.2M Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NIVF +18.53 pp
NIVF: -55.32% · BSLK: -73.85%
3M Horizon NIVF +149.83 pp
NIVF: +80.36% · BSLK: -69.47%
6M Horizon NIVF +149.83 pp
NIVF: +80.36% · BSLK: -69.47%
1Y Horizon NIVF +149.83 pp
NIVF: +80.36% · BSLK: -69.47%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period NIVF Revenue BSLK Revenue NIVF Op. Margin BSLK Op. Margin Margin Leader
Q4 '24 N/A $10M N/A -504.4% BSLK
Q1 '25 N/A $0M N/A -3157.9% BSLK
Q2 '25 N/A $10M N/A -370.0% BSLK
Q3 '25 $10M $0M -195.9% -1179.5% NIVF
Q4 '25 $10M N/A -349.1% N/A NIVF

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NIVF UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NIVF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BSLK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BSLK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NIVF Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $369,508 market capitalization and -238.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
BSLK Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $7.1M market capitalization and -1179.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ NIVF vs BSLK Key Questions & Quantitative Answers

As of Nov 16, 2026, NewGenIvf Group Limited Class A (NIVF) is the stronger overall head-to-head candidate over Bolt Projects Holdings, Inc. (BSLK) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 2–1 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow). NIVF carries a Unified Composite Score of 42.4/100 (HOLD) at $0.20 (N/M Forward P/E, -238.2% operating margin), whereas BSLK carries 41.2/100 (SELL) at $0.58 (N/M Forward P/E, -1179.5% operating margin). Growth vs. Quality Trade-Off: NIVF earns the overall head-to-head edge with a stronger Unified Composite Score (42.4/100 HOLD vs. BSLK 41.2/100 SELL) and 0.07β · 3093% Vol risk profile, whereas BSLK leads top-line expansion (+7300.0% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: NIVF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.2); meanwhile BSLK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 19.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BSLK leads the Growth & Scale pillar: NIVF posts -4.7% YoY revenue growth and +0.0% YoY earnings growth on $4.6M TTM revenue (23.9% gross margin, -238.2% operating margin), compared with BSLK at +7300.0% YoY revenue growth and +0.0% YoY earnings growth on $3.1M TTM revenue (3.2% gross margin, -1179.5% operating margin). Across the 5-period historical trajectory (Q4 '24 to Q4 '25), NIVF cumulative revenue shifted +0.0% while BSLK shifted +0.0%. In operating R&D and SG&A reinvestment, NIVF deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BSLK.

NIVF and BSLK trade at balanced relative valuation multiples. NIVF trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (unreported EBITDA margin), whereas BSLK trades at N/M Forward P/E, 0.1x Trailing P/E, N/M PEG, and 4.9x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NIVF (5.5% ROE) versus BSLK (-4288.3% ROE) capital efficiency.

In options market volatility and institutional positioning, NIVF carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.07β · 3093% Vol realized risk). By comparison, BSLK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.04β · 148% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.